D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 80 Citations 19,733 472 World Ranking 1447 National Ranking 88

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Gene
  • Organic chemistry

Hiroshi Yamazaki mostly deals with Biochemistry, Cytochrome P450, Microsome, Enzyme and CYP3A4. His work in Biochemistry is not limited to one particular discipline; it also encompasses Stereochemistry. His biological study spans a wide range of topics, including Metabolite, Cytochrome and Drug metabolism.

His Microsome research is multidisciplinary, incorporating elements of Cytochrome P-450 CYP3A, Isozyme, Internal medicine and Endocrinology. As part of the same scientific family, Hiroshi Yamazaki usually focuses on Enzyme, concentrating on Peptide sequence and intersecting with Molecular biology. His CYP3A4 study frequently links to other fields, such as Pharmacology.

His most cited work include:

  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. (2495 citations)
  • Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1 (720 citations)
  • Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes (337 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Cytochrome P450, Biochemistry, Pharmacology, Microsome and Enzyme. His work carried out in the field of Cytochrome P450 brings together such families of science as Molecular biology, Drug metabolism and Hydroxylation. His Molecular biology research is multidisciplinary, relying on both Complementary DNA and Genetics.

His Biochemistry study frequently involves adjacent topics like Stereochemistry. His research integrates issues of Metabolite and In vivo in his study of Pharmacology. His Microsome study combines topics from a wide range of disciplines, such as Endocrinology, Monooxygenase, Cytochrome P-450 CYP3A, Internal medicine and Isozyme.

He most often published in these fields:

  • Cytochrome P450 (19.98%)
  • Biochemistry (18.64%)
  • Pharmacology (18.26%)

What were the highlights of his more recent work (between 2016-2021)?

  • Pharmacology (18.26%)
  • Pharmacokinetics (8.70%)
  • Enzyme (13.10%)

In recent papers he was focusing on the following fields of study:

Hiroshi Yamazaki mainly investigates Pharmacology, Pharmacokinetics, Enzyme, Drug metabolism and Cytochrome P450. The concepts of his Pharmacology study are interwoven with issues in Metabolite, Thalidomide, Toxicity and In vivo. His Pharmacokinetics research includes elements of Oral administration, Chromatography and Glucuronide.

His research in Enzyme tackles topics such as Molecular biology which are related to areas like Amino acid. His Drug metabolism study also includes

  • Genetics, which have a strong connection to Monooxygenase,
  • CYP3A4 that connect with fields like Hydroxylation. His study with Cytochrome P450 involves better knowledge in Biochemistry.

Between 2016 and 2021, his most popular works were:

  • The Dihydroxy Metabolite of the Teratogen Thalidomide Causes Oxidative DNA Damage (22 citations)
  • Rigid-to-Flexible Conformational Transformation: An Efficient Route to Ring-Opening of a Tröger’s Base-Containing Ladder Polymer (19 citations)
  • Plasma and Hepatic Concentrations of Chemicals after Virtual Oral Administrations Extrapolated Using Rat Plasma Data and Simple Physiologically Based Pharmacokinetic Models. (16 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Gene
  • Internal medicine

Hiroshi Yamazaki focuses on Pharmacology, Pharmacokinetics, Drug metabolism, Cytochrome P450 and Marmoset. His studies in Pharmacology integrate themes in fields like In vitro, Thalidomide, Toxicity and In vivo. While the research belongs to areas of In vivo, Hiroshi Yamazaki spends his time largely on the problem of Microsome, intersecting his research to questions surrounding Hydroxylation.

His Pharmacokinetics research incorporates elements of Oral administration, Metabolite, CYP2C19 and Warfarin. His Drug metabolism research includes themes of CYP3A4, Nonsynonymous substitution and Gene, Gene isoform. His Cytochrome P450 study is concerned with the larger field of Biochemistry.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

T Shimada;H Yamazaki;M Mimura;Y Inui.
Journal of Pharmacology and Experimental Therapeutics (1994)

4085 Citations

Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1

Tsutomu Shimada;Carrie L. Hayes;Hiroshi Yamazaki;Shantu Amin.
Cancer Research (1996)

984 Citations

Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes

Hiroshi Yamazaki;Yukiharu Inui;Chul-Ho Yun;F.Peter Guengerich.
Carcinogenesis (1992)

466 Citations

Progesterone and Testosterone Hydroxylation by Cytochromes P450 2C19, 2C9, and 3A4 in Human Liver Microsomes

Hiroshi Yamazaki;Tsutomu Shimada.
Archives of Biochemistry and Biophysics (1997)

340 Citations

Activation and detoxication of aflatoxin B1

F P Guengerich;W W Johnson;T Shimada;Y F Ueng.
Mutation Research (1998)

338 Citations

Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens.

T. Shimada;Chul-Ho Yun;H. Yamazaki;J.-C. Gautier.
Molecular Pharmacology (1992)

308 Citations

Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs.

T. Shimada;H. Yamazaki;M. Mimura;N. Wakamiya.
Drug Metabolism and Disposition (1996)

305 Citations

Regio- and stereocontrolled dimerization of tert-butylacetylene to (Z)-1,4-di-tert-butylbutatriene by ruthenium catalysis. Reaction mechanism involving alkynyl-vinylidene coupling and rearrangement of the metal-bound C4 unit

Yasuo Wakatsuki;Hiroshi Yamazaki;Nami Kumegawa;Toshiaki Satoh.
Journal of the American Chemical Society (1991)

265 Citations

Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes.

Hiroshi Yamazaki;Kiyoshi Inoue;Masafumi Hashimoto;Tsutomu Shimada.
Archives of Toxicology (1999)

259 Citations

Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4/NADPH-cytochrome P450 reductase system and studies with apo-cytochrome b5.

Hiroshi Yamazaki;William W. Johnson;Yune-Fang Ueng;Tsutomu Shimada.
Journal of Biological Chemistry (1996)

254 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Hiroshi Yamazaki

F. Peter Guengerich

F. Peter Guengerich

Vanderbilt University

Publications: 129

Rachel F. Tyndale

Rachel F. Tyndale

Centre for Addiction and Mental Health

Publications: 113

Tsuyoshi Yokoi

Tsuyoshi Yokoi

Nagoya University

Publications: 97

Miki Nakajima

Miki Nakajima

Kanazawa University

Publications: 83

David J. Greenblatt

David J. Greenblatt

Tufts University

Publications: 58

Frank J. Gonzalez

Frank J. Gonzalez

National Institutes of Health

Publications: 56

Magnus Ingelman-Sundberg

Magnus Ingelman-Sundberg

Karolinska Institute

Publications: 56

Tetsuya Kamataki

Tetsuya Kamataki

Hokkaido University

Publications: 46

Xinxin Ding

Xinxin Ding

University of Arizona

Publications: 46

Marie Stiborová

Marie Stiborová

Charles University

Publications: 43

Nico P. E. Vermeulen

Nico P. E. Vermeulen

Vrije Universiteit Amsterdam

Publications: 40

Hannu Raunio

Hannu Raunio

University of Eastern Finland

Publications: 38

Kenneth E. Thummel

Kenneth E. Thummel

University of Washington

Publications: 38

Olavi Pelkonen

Olavi Pelkonen

University of Oulu

Publications: 36

Neal L. Benowitz

Neal L. Benowitz

University of California, San Francisco

Publications: 36

Amin Rostami-Hodjegan

Amin Rostami-Hodjegan

University of Manchester

Publications: 35

Trending Scientists

Benjamin Blankertz

Benjamin Blankertz

Technical University of Berlin

Nilanjan Sarkar

Nilanjan Sarkar

Vanderbilt University

Mitjan Kalin

Mitjan Kalin

University of Ljubljana

David F. Sorrells

David F. Sorrells

ParkerVision

Carmel Majidi

Carmel Majidi

Carnegie Mellon University

Chunxia Li

Chunxia Li

Chinese Academy of Sciences

Nianpeng He

Nianpeng He

Chinese Academy of Sciences

Marc D. Hauser

Marc D. Hauser

Harvard University

Isabelle Merlet

Isabelle Merlet

University of Rennes

David J. Calkins

David J. Calkins

Vanderbilt University Medical Center

Shimon Slavin

Shimon Slavin

Hebrew University of Jerusalem

Elliot M. Tucker-Drob

Elliot M. Tucker-Drob

The University of Texas at Austin

Paul Tornetta

Paul Tornetta

Boston Medical Center

Lars Alfredsson

Lars Alfredsson

Karolinska Institute

Detlev Ganten

Detlev Ganten

Charité - University Medicine Berlin

Garry Rodan

Garry Rodan

Murdoch University

Something went wrong. Please try again later.